产品
编 号：F416911
分子式：C18H18N2O2
分子量：294.35
分子式：C18H18N2O2
分子量：294.35
产品类型
规格
价格
是否有货
结构图
CAS No: 651029-09-3
产品详情
生物活性：
KCL-440 is a CNS-penetrated PARP inhibitor, with an IC50 of 68 nM. KCL-440 has strong inhibition of PARP-1.
体内研究：
The brain concentration of KCL-440 is sufficient to inhibit the PARP activity during the intravenous infusion at the rate of 1 mg/kg/h.KCL-440 (over 0.03 mg/kg/h) exhibits neuroprotective effects of KCL-440 in the in vivo cerebral ischemia model.Animal Model:Rat acute cerebral infarction model induced by photothrombotic MCA occlusion.
Dosage:0.01, 0.03, 0.1, 0.3, 1.0, and 3.0 mg/kg/h.
Administration:Intravenously administered at a rate of 0.33 ml/kg/h for 24 h immediately aftercerebral ischemia.
Result:The serum concentration of KCL-440 approached steadystate levels within 1 h in rats that were intravenously infused at the rate of 1 mg/kg/h for 6 h. One hour after the initiation of infusion, the serum concentration of KCL-440 is 0.11 μg/mL, which is equivalent to 0.37 μM. The brain:serum concentration ratio after a 6-h infusion at 10 mg/kg/h is 0.8.Led to a dose-dependent reduction in the cerebral infarct size at 24 h after the MCA occlusion.
KCL-440 is a CNS-penetrated PARP inhibitor, with an IC50 of 68 nM. KCL-440 has strong inhibition of PARP-1.
体内研究：
The brain concentration of KCL-440 is sufficient to inhibit the PARP activity during the intravenous infusion at the rate of 1 mg/kg/h.KCL-440 (over 0.03 mg/kg/h) exhibits neuroprotective effects of KCL-440 in the in vivo cerebral ischemia model.Animal Model:Rat acute cerebral infarction model induced by photothrombotic MCA occlusion.
Dosage:0.01, 0.03, 0.1, 0.3, 1.0, and 3.0 mg/kg/h.
Administration:Intravenously administered at a rate of 0.33 ml/kg/h for 24 h immediately aftercerebral ischemia.
Result:The serum concentration of KCL-440 approached steadystate levels within 1 h in rats that were intravenously infused at the rate of 1 mg/kg/h for 6 h. One hour after the initiation of infusion, the serum concentration of KCL-440 is 0.11 μg/mL, which is equivalent to 0.37 μM. The brain:serum concentration ratio after a 6-h infusion at 10 mg/kg/h is 0.8.Led to a dose-dependent reduction in the cerebral infarct size at 24 h after the MCA occlusion.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备